Chlormézanone

Chlormézanone may be available in the countries listed below.

Ingredient matches for Chlormézanone

Chlormezanone

Chlormézanone (DCF) is known as Chlormezanone in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Gabapentin Germed

Gabapentin Germed may be available in the countries listed below.

Ingredient matches for Gabapentin Germed

Gabapentin

Gabapentin is reported as an ingredient of Gabapentin Germed in the following countries:

• Italy

International Drug Name Search

Diphos

Diphos may be available in the countries listed below.

Ingredient matches for Diphos

Etidronic Acid

Etidronic Acid disodium salt (a derivative of Etidronic Acid) is reported as an ingredient of Diphos in the following countries:

• Germany

International Drug Name Search

Alglucosidase Alfa

In the US, Alglucosidase Alfa (alglucosidase alfa systemic) is a member of the drug class lysosomal enzymes and is used to treat Pompe disease.

US matches:

• Alglucosidase Alfa


• Alglucosidase alfa injection


• Alglucosidase alfa Intravenous

Ingredient matches for Alglucosidase Alfa

Alglucosidase Alfa

Alglucosidase Alfa (USAN) is known as Alglucosidase Alfa in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Losartas

Losartas may be available in the countries listed below.

Ingredient matches for Losartas

Losartan

Losartan is reported as an ingredient of Losartas in the following countries:

• Peru

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartas in the following countries:

• Myanmar

International Drug Name Search

Loridem

Loridem may be available in the countries listed below.

Ingredient matches for Loridem

Lorazepam

Lorazepam is reported as an ingredient of Loridem in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Sulperason

Sulperason may be available in the countries listed below.

Ingredient matches for Sulperason

Cefoperazone

Cefoperazone is reported as an ingredient of Sulperason in the following countries:

• Russian Federation

Sulbactam

Sulbactam is reported as an ingredient of Sulperason in the following countries:

• Russian Federation

International Drug Name Search

Gaosédal Codéine

Gaosédal Codéine may be available in the countries listed below.

Ingredient matches for Gaosédal Codéine

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Gaosédal Codéine in the following countries:

• France

Paracetamol

Paracetamol is reported as an ingredient of Gaosédal Codéine in the following countries:

• France

International Drug Name Search

Eraxis

Eraxis is a brand name of anidulafungin, approved by the FDA in the following formulation(s):

ERAXIS (anidulafungin - injectable; iv (infusion))

• 
  Manufacturer: VICURON
  
  Approval date: February 17, 2006
  
  Strength(s): 50MG/VIAL ^[RLD]


• 
  Manufacturer: VICURON
  
  Approval date: November 14, 2006
  
  Strength(s): 100MG/VIAL ^[RLD]

Has a generic version of Eraxis been approved?

No. There is currently no therapeutically equivalent version of Eraxis available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Eraxis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Cyclic peptide antifungal agents
  Patent 5,965,525
  Issued: October 12, 1999
  Inventor(s): Burkhardt; Frederick J. & Debono; Manuel & Nissen; Jeffrey S. & Turner, Jr.; William W.
  Assignee(s): Eli Lilly and Company
  Provided are compounds of the formula (1): ##STR1## wherein R' is hydrogen, methyl or NH.sub.2 C(O)CH.sub.2 --; R" and R'" are independently methyl or hydrogen; R and R.sup.y are independently hydroxy or hydrogen; R.sub.1 is hydroxy, hydrogen, or hydroxysulfonyloxy; R.sub.7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R.sub.2 is a novel acyl side chain. Also provided are novel formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R=H) forms of the compounds.
  
  Patent expiration dates:
  
  
  • February 17, 2020
    
    ✓ 
    Patent use: TREATMENT OF FUNGAL INFECTIONS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Cyclic peptide antifungal agents and process for preparation thereof
  Patent 6,384,013
  Issued: May 7, 2002
  Inventor(s): Frederick J.; Burkhardt & Manuel; Debono & Jeffrey S.; Nissen & William W.; Turner, Jr.
  Assignee(s): Eli Lilly and Company
  Provided are compounds of the formula (1): wherein R′ is hydrogen, methyl or NH2C(O)CH2—; R″ and R′″ are independently methyl or hydrogen; R and Ry are independently hydroxy or hydrogen; R1 is hydroxy, hydrogen, or hydroxysulfonyloxy; R7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R2 is a acyl side chain. Also provided are formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R═H) forms of the compounds.
  
  Patent expiration dates:
  
  
  • March 19, 2012
    
    ✓ 
    Drug substance
  
  



• 
  Cyclic peptide antifungal agents and process for preparation thereof
  Patent 6,743,777
  Issued: June 1, 2004
  Inventor(s): Frederick J.; Burkhardt & Manuel; Debono & Jeffrey S.; Nissen & William W.; Turner, Jr.
  Assignee(s): Eli Lilly and Company
  Provided are compounds of the formula (1): wherein R′ is hydrogen, methyl or NH2C(O)CH2—; R″ and R′″ are independently methyl or hydrogen; R adn Ry are independently hydroxy or hydrogen; R1 is hydroxy, hydrogen, or hydroxysulfonyloxy; R7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R2 is a novel acyl side chain. Also provided are novel formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R=H) forms of the compounds.
  
  Patent expiration dates:
  
  
  • March 19, 2012
    
    ✓ 
    Patent use: TREATMENT OF FUNGAL INFECTIONS
    ✓ 
    Drug product
  
  



• 
  Echinocandin pharmaceutical formulations containing micelle-forming surfactants
  Patent 6,960,564
  Issued: November 1, 2005
  Inventor(s): Milton; Nathaniel & Moder; Kenneth Philip & Sabatowski; James Lawrence & Sweetana; Stephanie Ann
  Assignee(s): Eli Lilly and Company
  Pharmaceutical formulations are described comprising an echinocandin compound or echinocandin/carbohydrate complex and a pharmaceutically acceptable micelle-forming surfactant in a non-toxic aqueous solvent such that the solubilization of the echinocandin compound is optimized and the ability to freeze-dry the solution is maintained. Both the solution and freeze-dried formulations have increased stability. A bulking agent, tonicity agent buffer and/or a stabilizing agent may optionally be added to the formulations to further enhance the stability of the formulation.
  
  Patent expiration dates:
  
  
  • April 12, 2021
    
    ✓ 
    Patent use: TREATMENT OF FUNGAL INFECTIONS
    ✓ 
    Drug product
  
  



• 
  Echinocandin pharmaceutical formulations containing micelle-forming surfactants
  Patent 7,709,444
  Issued: May 4, 2010
  Inventor(s): Milton; Nathaniel & Moder; Kenneth Philip & Sabatowski; James Lawrence & Sweetana; Stephanie Ann
  Assignee(s): Pfizer Inc.
  Pharmaceutical formulations are described comprising an echinocandin compound or echinocandin/carbohydrate complex and a pharmaceutically acceptable micelle-forming surfactant in a non-toxic aqueous solvent such that the solubilization of the echinocandin compound is optimized and the ability to freeze-dry the solution is maintained. Both the solution and freeze-dried formulations have increased stability. A bulking agent, tonicity agent buffer and/or a stabilizing agent may optionally be added to the formulations to further enhance the stability of the formulation.
  
  Patent expiration dates:
  
  
  • April 12, 2021
    
    ✓ 
    Patent use: TREATMENT OF FUNGAL INFECTIONS
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • February 17, 2011 - NEW CHEMICAL ENTITY
  
  

See also...

• Eraxis Consumer Information (Drugs.com)
• Eraxis Consumer Information (Wolters Kluwer)
• Eraxis Consumer Information (Cerner Multum)
• Eraxis Advanced Consumer Information (Micromedex)
• Eraxis AHFS DI Monographs (ASHP)
• Anidulafungin Consumer Information (Wolters Kluwer)
• Anidulafungin Consumer Information (Cerner Multum)
• Anidulafungin Intravenous Advanced Consumer Information (Micromedex)
• Anidulafungin AHFS DI Monographs (ASHP)

Colchicina Lirca

Colchicina Lirca may be available in the countries listed below.

Ingredient matches for Colchicina Lirca

Colchicine

Colchicine is reported as an ingredient of Colchicina Lirca in the following countries:

• Italy

International Drug Name Search

Lonazep

Lonazep may be available in the countries listed below.

Ingredient matches for Lonazep

Clonazepam

Clonazepam is reported as an ingredient of Lonazep in the following countries:

• Bangladesh


• India

International Drug Name Search

Pramiel

Pramiel may be available in the countries listed below.

Ingredient matches for Pramiel

Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Pramiel in the following countries:

• Japan

International Drug Name Search

Trimébutine Alter

Trimébutine Alter may be available in the countries listed below.

Ingredient matches for Trimébutine Alter

Trimebutine

Trimebutine maleate (a derivative of Trimebutine) is reported as an ingredient of Trimébutine Alter in the following countries:

• France

International Drug Name Search

Concor Cor

Concor Cor may be available in the countries listed below.

Ingredient matches for Concor Cor

Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Concor Cor in the following countries:

• Austria


• Bulgaria


• Croatia (Hrvatska)


• Czech Republic


• Georgia


• Hungary


• Lithuania


• Luxembourg


• Romania


• Russian Federation


• Vietnam

International Drug Name Search